Skip to main content

Table 2 Antibiotic susceptibility profile of staphylococci isolates recovered from general public settings

From: The prevalence, antibiotic resistance and mecA characterization of coagulase negative staphylococci recovered from non-healthcare settings in London, UK

Isolates No of isolates Resistance to a panel of 11 antibiotics (%)
  OX PG MUP CEF GM FC S A E T C
S. epidermidis 176 8 72 16 9 7 64 22 26 43 16 2
S. hominis 152 2 68 9 5 7 66 24 17 38 21 3
S. capitis 73 4 58 15 4 1 60 47 23 14 10 5
S. haemolyticus 40 10 50 13 23 15 68 73 45 0 25 10
S. warneri 63 3 54 17 10 22 59 51 40 27 16 2
S. pasteuri 31 6 69 13 6 9 69 25 31 44 17 3
S. saprophyticus 20 15 90 25 5 10 100 10 25 35 15 10
S. aureus 12 0 83 17 0 58 83 33 50 25 0 8
S. simiae 10 0 10 0 0 0 40 0 0 0 0 0
S. cohnii 9 24 67 11 33 0 78 78 22 56 11 0
S. sciuri 5 60 60 80 0 20 80 80 40 0 0 0
S. pettenkoferi 3 0 33 0 0 0 67 67 33 0 0 0
S. lugdunensis 2 0 50 0 0 0 50 0 0 0 0 0
S. equorum 2 0 50 50 0 0 50 50 50 0 50 0
S. caprae 2 0 100 0 100 100 100 50 50 0 0 0
S. xylosus 2 0 100 50 50 50 100 100 0 0 50 0
S. auricularis 2 0 50 0 50 0 50 0 50 0 0 0
S. arlettae 1 0 100 0 0 0 100 100 100 100 0 0
S. simulans 1 0 100 0 0 0 100 0 0 0 0 0
  1. OX oxacillin (1 μg), PG penicillin G (1 unit), MUP mupirocin (20 μg), CEF cefepime (30 μg), GM gentamicin (10 μg), FC fusidic acid (10 μg), S streptomycin (10 μg), A amoxicillin (10 μg), E erythromycin (5 μg), T tetracycline (10 μg), C chloramphenicol (30 μg)